Ayla Ellison

Editor-in-Chief Ayla Ellison and Fierce Pharma Marketing Senior Editor Ben Adams discuss the most anticipated drug launches of 2024, including a schizophrenia drug awaiting FDA approval, Bristol Myers Squibb's targeted launch plan, and Madrigal Pharmaceuticals' goal to become a leader in liver health.